ClinicalTrials.gg
RecruitingNCT07575425Updated May 8, 2026

Effects of Mobilized Balance Platform Exercises on Balance Parameters in Patients With Knee Osteoarthritis

An interventional study of Huber 360 Balance Training and Conventional Physical Therapy in Osteearthritis and Knee Arthritis, Osteoarthritis, sponsored by Gaziler Physical Medicine and Rehabilitation Education and Research Hospital. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 45 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-05-08.

Sponsored by Gaziler Physical Medicine and Rehabilitation Education and Research Hospital · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started May 2026; still recruiting 6 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
45 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 105 studies in Osteoarthritis with a site in Turkey — 22 open to participants now, 29 under way, none of them phase 3. Osteoarthritis · Turkey.

Planned enrollment
50th of 64
36 · median 54
Started
2026
with 12 others
No phase
60 of 105
12 open now
Primary completion
2026-09
later than 15 of 28 live
Registered
99th of 105
by date
Lead sponsor
2 of 105
Gaziler Physical Medicine and Rehabilitation Education and Research Hospital

Among the 105 studies in Osteoarthritis with a site in Turkey, this one is the 50th largest by planned enrollment of the 64 interventional ones that give a count, is one of 13 that started in 2026, is one of 60 with no phase, reaches primary completion later than 15 of the 28 other live ones, and was the 99th registered.

Osteoarthritis

2,974 studies on the registry are indexed under Osteoarthritis; 438 are open to participants now.

Browse Osteoarthritis studies →

Open to participants now

22 of the 105 studies in Osteoarthritis with a site in Turkey are open now. Recruiting first, the newest first:

16 more — sign in →

All 22 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 287 Osteoarthritis studies recruiting now, 158 (55%) set no upper age limit and 72 (25%) stop at 75 or younger; 22 take children under 18; 30 take healthy volunteers.

This study: 45 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 105 studies in Osteoarthritis with a site in Turkey, or all of them as a file.
02

Study summary

This prospective single-blind randomized controlled study aims to investigate the effects of mobilized balance platform exercises on balance parameters, pain, functional status, fear of falling, and kinesiophobia in patients with knee osteoarthritis. A total of 36 patients diagnosed with knee osteoarthritis will be recruited from the outpatient clinic of Gaziler Physical Medicine and Rehabilitation Training and Research Hospital.

Participants will be randomly assigned to one of two groups. The control group will receive conventional physical therapy including transcutaneous electrical nerve stimulation (TENS) and a home exercise program consisting of knee strengthening, balance, range of motion, proprioceptive, and stretching exercises. The intervention group will receive the same conventional treatment in addition to mobilized balance platform exercises using the Huber 360 system.

Pain severity, functional status, balance parameters, fear of falling, and kinesiophobia will be evaluated before and after treatment by an assessor blinded to treatment allocation.

03

Conditions studied

  • Osteearthritis
  • Knee Arthritis, Osteoarthritis

Browse trials for

04

Who can participate

Ages eligible
45 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients aged between 45 and 65 years
  • Diagnosis of knee osteoarthritis classified as Kellgren-Lawrence grade 2 or 3
  • Willingness to participate voluntarily in the study

Exclusion criteria

Exclusion Criteria:

  • Presence of orthopedic knee implants
  • Kellgren-Lawrence grade 1 or grade 4 knee osteoarthritis
  • Sensory impairment
  • Diagnosis of
  • Unhealed fractures
  • Circulatory disorders
  • Infection around the knee joint
  • Severe hearing loss or visual impairment
  • Cognitive impairment
  • Uncontrolled hypertension or diabetes mellitus
  • Vestibular disorders causing balance problems, such as vertigo
  • Use of walking assistive devices such as canes or walkers
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
36 participants (estimated)

Study arms

  • Active comparator
    Conventional Physical Therapy

    Participants in this group will receive conventional physical therapy including transcutaneous electrical nerve stimulation (TENS) and a home exercise program. The home exercise program will include knee strengthening, balance, range of motion, proprioceptive, and stretching exercises, performed 3 days per week for 20 minutes.

    Other: Conventional Physical Therapy

  • Experimental
    Mobilized Balance Platform Exercise

    Participants in this group will receive conventional physical therapy including TENS in addition to mobilized balance platform exercises using the Huber 360 system. The exercise protocol will include quadriceps and core strengthening, proprioceptive, balance, and neuromuscular exercises, performed 3 days per week for 20 minutes.

    Device: Huber 360 Balance Training · Other: Conventional Physical Therapy

Interventions

  • DeviceHuber 360 Balance Training

    Participants will perform mobilized balance platform exercises using the Huber 360 system. The exercise protocol will include quadriceps and core strengthening, proprioceptive training, balance exercises, and neuromuscular exercises specifically designed for patients with knee osteoarthritis. Sessions will be performed 3 times per week for 20 minutes.

  • OtherConventional Physical Therapy

    Participants will receive conventional physical therapy including transcutaneous electrical nerve stimulation (TENS) and a home exercise program consisting of knee strengthening, balance, range of motion, proprioceptive, and stretching exercises performed 3 times per week for 20 minutes.

06

What researchers measure

Primary outcomes

  1. Static and Dynamic Balance Parameters

    Balance performance will be assessed using the Huber 360 balance assessment system. Measurements will include static balance with eyes open and eyes closed, single-leg balance performance, and limits of stability.

    Time frame: Before treatment and immediately after completion of the 8-week treatment program

Secondary outcomes

  1. Pain Severity Assessed by Visual Analog Scale (VAS)

    Pain intensity will be assessed using a 10-cm Visual Analog Scale (VAS) for night pain, resting pain, and pain during movement. Higher scores indicate greater pain severity.

    Time frame: Before treatment and immediately after completion of the 8-week treatment program

  2. Functional Status Assessed by WOMAC

    Functional status will be evaluated using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). Higher scores indicate worse pain, stiffness, and functional limitation.

    Time frame: Before treatment and immediately after completion of the 8-week treatment program

  3. Functional Mobility Assessed by Timed Up and Go Test

    Functional mobility and dynamic balance will be assessed using the Timed Up and Go Test. Shorter completion times indicate better functional mobility.

    Time frame: Before treatment and immediately after completion of the 8-week treatment program

  4. Fear of Falling Assessed by the International Falls Efficacy Scale

    Fear of falling during activities of daily living will be evaluated using the International Falls Efficacy Scale. Higher scores indicate greater concern about falling.

    Time frame: Before treatment and immediately after completion of the 8-week treatment program

  5. Kinesiophobia Assessed by Tampa Scale for Kinesiophobia

    Fear of movement and reinjury will be evaluated using the Tampa Scale for Kinesiophobia. Higher scores indicate greater fear of movement.

    Time frame: Before treatment and immediately after completion of the 8-week treatment program

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2026 (actual). Primary completion is estimated for Sep 2026, 4 months after the start.

Of 578 non-industry interventional studies with no phase under Osteoarthritis, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 52. This study's planned 4 months is below that.

Counting every sponsor, half of 713 studies reached it within 29 months; a quarter within 11 and three quarters within 58.

How these figures are worked out, and which studies are left out of them.

Registered
May 3, 2026
First posted
May 8, 2026
StartActual
May 4, 2026
Primary completionEst.
Sep 30, 2026
CompletionEst.
Oct 30, 2026
Last update
May 8, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07575425
Lead sponsor
Gaziler Physical Medicine and Rehabilitation Education and Research Hospital
Responsible party
Sefa Gümrük Aslan (Assistant professor, Gaziler Physical Medicine and Rehabilitation Education and Research Hospital) — Principal investigator
First posted
May 8, 2026
Start date
May 4, 2026
Primary completion
Sep 30, 2026 (estimated)
Completion
Oct 30, 2026 (estimated)
Last update
May 8, 2026

Study contacts

SEFA GÜMRÜK ASLAN
Contact
sefagumrukk@gmail.com
+903122911503
Sefa Gümrük Aslan
principal investigator · gaziler physcial therapy and rehabilitation hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion